Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial
- Paolo Strati
- Lei Feng
- Jason R. Westin
- Ranjit Nair
- Luis E. Fayad
- Maria A. Rodriguez
- Dai Chihara
- Luis Malpica
- Jared Henderson
- Mariana Gallardo
- Marissa Rivera
- Iris Wang
- Anastasiia Bolshakova
- Anastasia Radko
- David Kurtz
- Stefan K. Alig
- Christopher R. Flowers
- Ash A. Alizadeh
- Sattva S. Neelapu
2025-08-07